Literature DB >> 22620974

Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide.

Roberto Adamo1, Maria R Romano, Francesco Berti, Rosanna Leuzzi, Marta Tontini, Elisa Danieli, Emilia Cappelletti, Osman S Cakici, Erwin Swennen, Vittoria Pinto, Barbara Brogioni, Daniela Proietti, Cesira L Galeotti, Luigi Lay, Mario A Monteiro, Maria Scarselli, Paolo Costantino.   

Abstract

Clostridium difficile is emerging worldwide as a major cause of nosocomial infections. The negatively charged PSII polysaccharide has been found in different strains of C. difficile and, thereby, represents an important target molecule for a possible carbohydrate-based vaccine. In order to identify a synthetic fragment that after conjugation to a protein carrier could be able to induce anti-PSII antibodies, we exploited a combination of chemical synthesis with immunochemistry, confocal immunofluorescence microscopy, and solid state NMR. We demonstrate that the phosphate group is crucial in synthetic glycans to mimic the native PSII polysaccharide; both native PSII and a phosphorylated synthetic hexasaccharide repeating unit conjugated to CRM(197) elicit comparable immunogenic responses in mice. This finding can aid design and selection of carbohydrate antigens to be explored as vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22620974     DOI: 10.1021/cb300221f

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  23 in total

Review 1.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

Review 2.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

3.  Chemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation.

Authors:  Wenjing Shang; Zhongying Xiao; Zaikuan Yu; Na Wei; Guohui Zhao; Qing Zhang; Mohui Wei; Xuan Wang; Peng George Wang; Tiehai Li
Journal:  Org Biomol Chem       Date:  2015-03-12       Impact factor: 3.876

4.  Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.

Authors:  Tyler D Moeller; Kevin B Weyant; Matthew P DeLisa
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  Biofilm formation by Clostridium difficile.

Authors:  Tanja Dapa; Meera Unnikrishnan
Journal:  Gut Microbes       Date:  2013-07-25

6.  Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.

Authors:  Tanja Ðapa; Tanja Dapa; Rosanna Leuzzi; Yen K Ng; Soza T Baban; Roberto Adamo; Sarah A Kuehne; Maria Scarselli; Nigel P Minton; Davide Serruto; Meera Unnikrishnan
Journal:  J Bacteriol       Date:  2012-11-21       Impact factor: 3.490

7.  Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.

Authors:  Andrew D Cox; Frank St Michael; Annie Aubry; Chantelle M Cairns; Philippa C R Strong; Alexander C Hayes; Susan M Logan
Journal:  Glycoconj J       Date:  2013-08-23       Impact factor: 2.916

8.  α-Galactosylceramide-Reactive NKT Cells Increase IgG1 Class Switch against a Clostridioides difficile Polysaccharide Antigen and Enhance Immunity against a Live Pathogen Challenge.

Authors:  Gillian A Lang; Binu Shrestha; Souwelimatou Amadou Amani; Tyler M Shadid; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2021-08-23       Impact factor: 3.441

9.  Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.

Authors:  Maria R Romano; Rosanna Leuzzi; Emilia Cappelletti; Marta Tontini; Alberto Nilo; Daniela Proietti; Francesco Berti; Paolo Costantino; Roberto Adamo; Maria Scarselli
Journal:  Toxins (Basel)       Date:  2014-04-22       Impact factor: 4.546

10.  Synthetically defined glycoprotein vaccines: current status and future directions.

Authors:  Roberto Adamo; Alberto Nilo; Bastien Castagner; Omar Boutureira; Francesco Berti; Gonçalo J L Bernardes
Journal:  Chem Sci       Date:  2013-05-16       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.